BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2096698)

  • 21. Phospholipase A2--role and function in inflammation. Based on the proceedings of the Symposium on Phospholipase A2: Pathophysiological Role of Soluble and Membrane-Bound Enzymes. January 15, 1989, New York, New York and the Federation of American Societies for Experimental Biology Symposium on the Release and Function of Phospholipase A2. March 22, 1989, New Orleans, Louisiana.
    Adv Exp Med Biol; 1990; 275():1-191. PubMed ID: 2239441
    [No Abstract]   [Full Text] [Related]  

  • 22. A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C.
    Felder CC; Dieter P; Kinsella J; Tamura K; Kanterman RY; Axelrod J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1140-7. PubMed ID: 2124620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular phospholipase A2 activity in two in vivo models of inflammation.
    Gans KR; Lundy SR; Dowling RL; Mackin WM; Stevens TM; Kerr JS
    Adv Exp Med Biol; 1990; 275():155-67. PubMed ID: 2122642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological control of phospholipase A2 activity in vitro and in vivo.
    Marshall LA; Chang JY
    Adv Exp Med Biol; 1990; 275():169-82. PubMed ID: 2239444
    [No Abstract]   [Full Text] [Related]  

  • 25. Extracellular phospholipase A2 mediates inflammatory hyperaemia.
    Vadas P; Wasi S; Movat HZ; Hay JB
    Nature; 1981 Oct 15-21; 293(5833):583-5. PubMed ID: 7290193
    [No Abstract]   [Full Text] [Related]  

  • 26. Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis.
    Pruzanski W; Vadas P
    J Rheumatol; 1988 Nov; 15(11):1601-3. PubMed ID: 3070027
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils.
    Marshall J; Krump E; Lindsay T; Downey G; Ford DA; Zhu P; Walker P; Rubin B
    J Immunol; 2000 Feb; 164(4):2084-91. PubMed ID: 10657662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin mediates lysis of erythrocytes by bee venom phospholipase A2 activated with oleoyl imidazolide.
    Drainas D; Lawrence AJ
    FEBS Lett; 1980 May; 114(1):93-7. PubMed ID: 7380019
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium dependency of prostaglandin E2 production in rat glomerular mesangial cells. Evidence that protein kinase C modulates the Ca2+-dependent activation of phospholipase A2.
    Bonventre JV; Swidler M
    J Clin Invest; 1988 Jul; 82(1):168-76. PubMed ID: 3164726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification mechanisms of inflammation: paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A2 is regulated by cytosolic phospholipase A2-derived hydroperoxyeicosatetraenoic acid.
    Balboa MA; Pérez R; Balsinde J
    J Immunol; 2003 Jul; 171(2):989-94. PubMed ID: 12847271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradykinin-induced translocation of cytoplasmic phospholipase A2 in MDCK cells.
    Kennedy C; Proulx PR; Hébert RL
    Can J Physiol Pharmacol; 1997 Jun; 75(6):563-7. PubMed ID: 9276129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective release of phospholipase A2 by resident mouse peritoneal macrophages.
    Wightman PD; Dahlgren ME; Davies P; Bonney RJ
    Biochem J; 1981 Nov; 200(2):441-4. PubMed ID: 7340844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate.
    Forst S; Weiss J; Elsbach P; Maraganore JM; Reardon I; Heinrikson RL
    Biochemistry; 1986 Dec; 25(26):8381-5. PubMed ID: 3548813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipase A2 and inflammation.
    Pruzanski W; Vadas P
    Ann Rheum Dis; 1989 Nov; 48(11):962-3. PubMed ID: 2596887
    [No Abstract]   [Full Text] [Related]  

  • 35. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medium viscosity regulates the activity of membrane-bound and soluble phospholipase A2.
    Yedgar S; Reisfeld N; Halle D; Yuli I
    Biochemistry; 1987 Jun; 26(12):3395-401. PubMed ID: 2958081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial purification and properties of phospholipase A2 from rat liver mitochondria.
    Natori Y; Karasawa K; Arai H; Tamori-Natori Y; Nojima S
    J Biochem; 1983 Feb; 93(2):631-7. PubMed ID: 6841360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrolysis of mixed monomolecular films of phosphatidylcholine/triacylglycerol by pancreatic phospholipase A2.
    Pieroni G; Verger R
    Eur J Biochem; 1983 May; 132(3):639-44. PubMed ID: 6852018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase A2 and spinal cord injury: a novel target for therapeutic intervention.
    Olivas AD; Noble-Haeusslein LJ
    Ann Neurol; 2006 Apr; 59(4):577-9. PubMed ID: 16566026
    [No Abstract]   [Full Text] [Related]  

  • 40. Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation.
    Pinto F; Brenner T; Dan P; Krimsky M; Yedgar S
    Glia; 2003 Dec; 44(3):275-82. PubMed ID: 14603468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.